Skip to main content
. 2017 Nov 1;8(59):100296–100311. doi: 10.18632/oncotarget.22220

Table 2. The distributions of concentrations of tamoxifen and its metabolites in 550 plasma specimens of 281 patients.

Variables Concentrations (95% CI) in ng/mL
Endoxifen NDM Tam 4-OH Tam Endoxifen /NDM Endoxifen /4-OH Tam NDM /Tam 4-OH Tam /Tam
Mean 25.0
(24.2-25.8)
230
(221-240)
128
(124-133)
8.53
(8.26-8.80)
0.13
(0.12-0.14)
4.27
(3.29-5.25)
1.83
(1.78-1.87)
0.08
(0.07-0.08)
SD 9.47 108 54.5 3.21 0.09 11.7 0.54 0.04
CV 38% 47% 43% 38% 69% 274% 30% 50%
5th percentile 12.5
(11.4-13.6)
80.5
(71.5-92.8)
50.3
(44.6-56.0)
2.60
(2.00-3.40)
0.05
(0.05-0.05)
1.82
(1.74-1.86)
1.18
(1.12-1.24)
0.02
(0.01-0.02)
25th percentile 18.5
(17.7-19.4)
157
(145-168)
89.4
(83.5-95.2)
6.70
(6.20-7.20)
0.08
(0.08-0.08)
2.37
(2.30-2.45)
1.51
(1.48-1.58)
0.05
(0.05-0.06)
50th percentile 23.4
(22.5-24.4)
223
(215-231)
123
(117-129)
8.75
(8.50-9.00)
0.11
(0.10-0.11)
2.82
(2.76-2.87)
1.79
(1.74-1.82)
0.08
(0.07-0.08)
75th percentile 30.2
(29.1-31.2)
282
(271-298)
158
(153-165)
10.4
(10.1-10.7)
0.15
(0.14-0.17)
3.45
(3.33-3.62)
2.08
(2.03-2.14)
0.10
(0.09-0.10)
95th percentile 42.7
(40.1-44.8)
413
(380-438)
231
(218-245)
13.4
(12.9-14.4)
0.29
(0.26-0.33)
7.18
(5.40-9.05)
2.53
(2.45-2.69)
0.14
(0.13-0.15)

CI, confidence interval; CV, coefficient of variation; NDM, N-desmethyltamoxifen; 4-OH Tam, 4-hydroxytamoxifen; SD, standard deviation; Tam, tamoxifen.